Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01573195 · ClinicalTrials.gov registry record
Merck IISP Stewardship Grant for Antibiotic Best Practices
A clinical trial of Antibiotic Resistant Infection, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 1,285
- Enrollment target
- 1
- Study location
NCT01573195: Completed study of Antibiotic Resistant Infection, sponsored by University of Wisconsin, Madison.
NCT01573195 is a study of Antibiotic Resistant Infection that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,285 participants, below the 11,642-participant average among 4 other Antibiotic Resistant Infection trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01573195, a study of Antibiotic Resistant Infection, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 1,285 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot the use of best practices alerts to enhance an antimicrobial stewardship program using the electronic medical record, EPIC.
Primary Outcome
after issuing the BPA for deescalation, the responding healthcare provider will respond in one of the manners above
Conditions Studied
Study Locations (1)
Wisconsin
- University of Wisconsin Hospitals and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,285 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-04 |
What the finished NCT01573195 record still lists
NCT01573195 is an observational study that tracks outcomes without assigning an intervention. Its 1,285 participants enrollment target places it among the larger protocols in the corpus, below the 11,642-participant average among 4 other Antibiotic Resistant Infection trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Antibiotic Resistant Infection appearing as the primary indexed condition, and to 0 interventions.
NCT01573195 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01573195 about?
NCT01573195 is a clinical study titled "Merck IISP Stewardship Grant for Antibiotic Best Practices". The purpose of this study is to pilot the use of best practices alerts to enhance an antimicrobial stewardship program using the electronic medical record, EPIC.
What is the current status of trial NCT01573195?
This trial is currently completed. The enrollment target is 1,285 participants. The study started on 2011-03. Estimated completion is 2012-04.
What conditions does trial NCT01573195 study?
This clinical trial studies the following conditions: Antibiotic Resistant Infection.
Who is sponsoring clinical trial NCT01573195?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01573195 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Antibiotic Resistant Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
-
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
RECRUITING
-
Probiotics and Multi-Drug Resistant Urinary Tract Infection
COMPLETED · NA
-
Inulin for Infections in the Intensive Care Unit
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia